
Dr Srija Moulik
Academic and research departments
School of Veterinary Medicine, Faculty of Health and Medical Sciences.About
Biography
Dr. Srija Moulik hold a Ph.D. in Biotechnology from the University of Calcutta, India, with a specialization in infectious diseases. Her doctoral research focused on the development of molecular techniques and immunological tools, particularly in the areas of gene expression, diagnostics, and therapeutics related to infectious and neglected tropical diseases. The primary emphasis of her research was on molecular and translational immunology, aiming to bridge the gap between laboratory research and clinical application.
In her current role as Research Fellow A (PDRA) at vHive, her work involves adapting volumetric absorptive microsampling (VAMS) methodologies—originally developed for human clinical studies—for application in veterinary science. This includes evaluating the use of Neoteryx sampling devices for omics-based analyses and drug detection in samples collected from companion animals and livestock. These samples will be analyzed through proteomic and metabolomic approaches, with data interpretation facilitated by appropriate bioinformatics pipelines and machine learning tools.
The objective is to develop a comprehensive and user-friendly standard operating procedure (SOP) for field deployment of these sampling tools, ensuring accessibility for use on farms, in veterinary clinics, or in domestic settings. The research also involves validating assay performance with robust statistical support. Ultimately, we aim to deliver a complete, reliable system for remote collection and transport of stable biofluid samples, enabling practical and effective remote diagnostics in animal health.
Sustainable development goals
My research interests are related to the following:





Publications
Highlights
- Roy S, Moulik S, Chaudhuri SJ, Ghosh MK, Goswami RP, Saha B, Chatterjee M. Molecular monitoring of treatment
efficacy in human visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2024 Jan 15: trad103. - Wijnant GJ, Moulik S, Chatterjee K, Das NK, de la Flor R, Van Bocxlaer K, Croft SL, Chatterjee M. Dermal microdialysis:
A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL). Exp Parasitol.
2024 Feb;257: 108687. - Sengupta R, Mitra S, Dighal A, Moulik S, Chaudhuri SJ, Das NK, Chatterjee U, Chatterjee M. Does immune dysregulation
contribute towards development of hypopigmentation in Indian post kala-azar dermal leishmaniasis? Exp Dermatol. 2023 Feb 9. doi: 10.1111/exd.14760. - Moulik S, Sengupta R, Ghosh MK, Das NK, Saha B, Chatterjee M. Liposomal amphotericin B is more effectivein
polymorphic lesions of post kala-azar dermal leishmaniasis. Indian J Dermatol Venereol Leprol. 2022 Mar-Apr; 88(2):201-
206. - Puri M, Brar HK, Mittal N, Madan E, Srinivasan R, Rawat K, Moulik S, Chatterjee M, Gorthi SS, MuthuswamiR,
Madhubala R. Rapid diagnosis of Leishmania infection with a portable loop-mediated isothermal amplification device. J
Biosci. 2021;46(4):92. - Dey NS, Senaratne S, Somaratne V, Madarasinghe NP, Seneviratne B, Forrester S, Montes de Oca M, Reis LC,Moulik
S, Walrad PB, Chatterjee M, Goto H, Wickremasinghe R, Lagos D, Kaye PM, Ranasinghe S. Early reduction in PD-L1
expression predicts faster treatment response in human cutaneous leishmaniasis. J Clin Invest. 2021 Nov
15;131(22):e142765. - Moulik S, Sengupta S, Chatterjee M. Molecular Tracking of the Leishmania Parasite. Front Cell Infect Microbiol. 2021 Feb
22;11:623437. - Moulik S, Karmakar J, Joshi S, Dube A, Mandal C, Chatterjee M. Status of IL-4 and IL- 10 driven markers in experimental
models of Visceral Leishmaniasis. Parasite Immunol. 2021 Jan;43(1):e12783. - Chatterjee M, Sengupta R, Mukhopadhyay D, Mukherjee S, Dighal A, Moulik S, Sengupta S. Immune Responses in Post
Kala-azar Dermal Leishmaniasis. Indian J Dermatol. 2020 Nov-Dec;65(6):452-460. - Dighal A, Mukhopadhyay D, Sengupta R, Moulik S, Mukherjee S, Roy S, Chaudhuri SJ, Das NK, Chatterjee M. Iron
trafficking in patients with Indian Post kala-azar dermal leishmaniasis. PLoS Negl Trop Dis. 2020 Feb 5;14(2):e0007991. - Moulik S, Sengupta R, Dighal A, Sardar B, Saha B, Das NK, Chatterjee M. Identification of atypical dermal leishmaniasis
resolved by restriction fragment length polymorphism. Indian J Dermatol Venereol Leprol. 2020 Jan-Feb;86(1):45-49. - Sengupta R, Mukherjee S, Moulik S, Mitra S, Chaudhuri SJ, Das NK, Chatterjee U, Chatterjee M. In-situ immune
profile of polymorphic vs. macular Indian Post Kala-azar dermal leishmaniasis. Int J Parasitol Drugs Drug Resist. 2019
Dec;11:166-176. - Sengupta R, Chaudhuri SJ, Moulik S, Ghosh MK, Saha B, Das NK, Chatterjee M. Active surveillance identified a neglected
burden of macular cases of Post Kala-azar Dermal Leishmaniasis in West Bengal. PLoS Negl Trop Dis. 2019 Mar
11;13(3):e0007249. - Roy S, Mukhopadhyay D, Mukherjee S, Moulik S, Chatterji S, Brahme N, Pramanik N, Goswami RP, Saha B, Chatterjee
M. An IL-10 dominant polarization of monocytes is a feature of Indian Visceral Leishmaniasis. Parasite Immunol. 2018 Jul;
40(7):e12535. Moulik S, Chaudhuri SJ, Sardar B, Ghosh M, Saha B, Das NK, Chatterjee M. Monitoring of Parasite Kinetics in Indian
Book Chapters
1. Chatterjee M, Moulik S, Dey D, Mukhopadhyay D, Mukherjee S and Roy S. Molecular Regulation of Macrophage Class Switching in
Indian Post-kala-azar Dermal Leishmaniasis (PKDL). Molecular Biology of Kinetoplastid Parasites (Edited by: Hemanta K. Majumder).
Caister Academic Press, U.K. (2018) Pages: 81-96.